We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
TGA laboratory testing reports
Any health product on our register may be sampled by our Laboratories Branch and tested. We publish these detailed reports for specific testing projects.
For more information about our laboratory testing see TGA Laboratories: What we test, how we test and what we do with our results.
Latest TGA laboratory testing reports
-
TGA laboratory testing reportsThe Therapeutic Goods Administration (TGA) is issuing a safety advisory regarding imported unregistered melatonin products following testing by TGA Laboratories.
-
TGA laboratory testing reportsIn response to increased adverse event reports, the TGA has investigated Vyvanse products, which included laboratory testing to assess the quality of the 6 different strengths of Vyvanse products.
-
TGA laboratory testing reportsThis study by the TGA assesses the particle filtration efficiency of respirators listed in the ARTG or submitted for compliance testing during the COVID-19 pandemic.
-
TGA laboratory testing reportsFace masks that are intended by their manufacturer to prevent the transmission of diseases between people or are intended to be used in a healthcare environment, are medical devices
-
TGA laboratory testing reportsTGA laboratories Branch tested various seasonal influenza vaccine batches.
-
TGA laboratory testing reportsBetween November 2024 and April 2025, TGA, Laboratories Branch tested various Heparin products
-
TGA laboratory testing reportsThis report summarises the extensive batch release testing activities undertaken by the TGA Laboratories for COVID-19 mRNA vaccines.
-
TGA laboratory testing reportsThis survey focused on single-ingredient vitamin D3 products with high sales volumes in Australia between January and December 2023. The TGA tested 13 of the top-selling products, which were supplied by nine different sponsors.
-
Summary report of residual DNA and endotoxin on COVID-19 mRNA vaccines conducted by TGA Laboratories
TGA laboratory testing reportsThe TGA has conducted a comprehensive evaluation of the residual DNA and endotoxin levels in the two mRNA vaccines supplied in Australia - Comirnaty (Pfizer) and Spikevax (Moderna). -
TGA laboratory testing reportsMedicinal cannabis products are permitted to be supplied into Australia under the Special Access Scheme, by authorised prescribers, and/or for use in clinical trials.